equisolon
le vet b.v. - prednisolone - kortikosteroīdi sistēmiskai lietošanai, vienkāršā, prednizolons, sistēmisko hormonālo preparātu, bez pvn). dzimumhormonus un insulīnu - zirgi - iekaisuma un klīnisko parametru, kas saistīti ar recidivējošu elpceļu obstrukciju (rao), atvieglojums zirgiem kopā ar vides kontroli.
prednisolone "Ņižfarm" 5 mg/g ziede
as Ņižfarm pārstāvniecība, latvija - prednizolons - ziede - 5 mg/g
abiraterone accord
accord healthcare s.l.u. - abiraterona acetāts - prostatas audzēji - endokrīnā terapija - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone mylan
mylan ireland limited - abiraterona acetāts - prostatas audzēji - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone krka
krka, d.d., novo mesto - abiraterona acetāts - prostatas audzēji - endokrīnā terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
xofigo
bayer ag - rādija (223ra) dihlorīds - prostatas audzēji - terapeitiskie radiofarmaceitiskie preparāti - xofigo ir indicēts pieaugušajiem ar kastrācijas rezistentu prostatas vēzi, simptomātiskas metastāzēs kauliem un nav zināma viscerālo metastāžu ārstēšanai.
solu-medrol 250 mg pulveris un šķīdinātājs injekciju šķīduma pagatavošanai
pfizer europe ma eeig, united kingdom - metilprednizolons - pulveris un šķīdinātājs injekciju šķīduma pagatavošanai - 250 mg
solu-medrol 1000 mg pulveris un šķīdinātājs injekciju šķīduma pagatavošanai
pfizer hellas a.e., greece - metilprednizolons - pulveris un šķīdinātājs injekciju šķīduma pagatavošanai - 1000 mg
solu-medrol 500 mg pulveris un šķīdinātājs injekciju šķīduma pagatavošanai
pfizer hellas a.e., greece - metilprednizolons - pulveris un šķīdinātājs injekciju šķīduma pagatavošanai - 500 mg
solu-medrol 40 mg/ml pulveris un šķīdinātājs injekciju šķīduma pagatavošanai
pfizer spol. s.r.o., czech republic - metilprednizolons - pulveris un šķīdinātājs injekciju šķīduma pagatavošanai - 40 mg